Decision Diagnostics Financials
| DECN Stock | USD 0.0001 0.00 0.00% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Debt Equity Ratio | 5.51 | 5.24 |
|
| |||||
| Current Ratio | 0.28 | 0.3 |
|
|
Investors should never underestimate Decision Diagnostics' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Decision Diagnostics' cash flow, debt, and profitability to make informed and accurate decisions about investing in Decision Diagnostics.
Net Income |
|
Decision | Select Account or Indicator |
Understanding current and past Decision Diagnostics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Decision Diagnostics' financial statements are interrelated, with each one affecting the others. For example, an increase in Decision Diagnostics' assets may result in an increase in income on the income statement.
Decision Diagnostics Stock Summary
Decision Diagnostics competes with Alibaba Health, Alibaba Health, SunLink Health, China Jo, and PetMed Express. Decision Diagnostics Corp. develops smart phone based electronic medical record technologies. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California. Decision Diagnostics operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 6 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | OTCCE Exchange |
| ISIN | US2434431084 |
| Business Address | 2660 Townsgate Road, |
| Sector | Health Care Technology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.decisiondiagnostics.co |
| Phone | 805 446 1973 |
| Currency | USD - US Dollar |
Decision Diagnostics Key Financial Ratios
| Return On Equity | -81.61 | ||||
| Operating Margin | (0.95) % | ||||
| Price To Sales | 0.02 X | ||||
| Revenue | 1.98 M | ||||
| Gross Profit | 462.23 K |
Decision Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Decision Diagnostics's current stock value. Our valuation model uses many indicators to compare Decision Diagnostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Decision Diagnostics competition to find correlations between indicators driving Decision Diagnostics's intrinsic value. More Info.Decision Diagnostics is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . At this time, Decision Diagnostics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Decision Diagnostics' earnings, one of the primary drivers of an investment's value.Decision Diagnostics Systematic Risk
Decision Diagnostics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Decision Diagnostics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Decision Diagnostics correlated with the market. If Beta is less than 0 Decision Diagnostics generally moves in the opposite direction as compared to the market. If Decision Diagnostics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Decision Diagnostics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Decision Diagnostics is generally in the same direction as the market. If Beta > 1 Decision Diagnostics moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Decision Diagnostics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Decision Diagnostics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Decision Diagnostics growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.